John A. Stalfort III - Jul 5, 2022 Form 4 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
VRCA
Transactions as of
Jul 5, 2022
Transactions value $
$500,000
Form type
4
Date filed
7/5/2022, 04:11 PM
Previous filing
Jun 17, 2022
Next filing
Jun 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRCA Common Stock Purchase $500K +238K +51.52% $2.10 700K Jul 5, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.